Company: BDRX
Filing Date: 2025-01-08
Form Type: 424B3
Source: 0001214659-25-000303
Chunk: 25

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-08
Form: 424B3
Chunk 25
---
 national newspaper published in the country in which the Company’s Registered Office is located      
 and in a newspaper circulating in the area in which the address in the Register of Members or other last known address of the member or     
 the person entitled by transmission to the share or the address for the service of notices on such member or person notified to the Company 
 in accordance with these Articles is located;                                                                                               |

| 16 |

| (C) | such advertisements, if not published on the same day, are published within thirty (30) days of each other; |

| (D) | during a further period of three (3) months following the date of publication of such advertisements (or,                                       
 if published on different dates, the date on which the requirements of this Article 31.1 concerning the publication of newspaper advertisements 
 are met) and prior to the sale the Company has not received any communication (whether in writing or otherwise) in respect of such share        
 from the member or person entitled by transmission; and                                                                                         |

| (E) | if such share is listed or dealt in on any stock exchange, the Company has first given notice in writing 
 to that exchange (where required) of its intention to sell such share.                                   |

| 31.2 | If during such twelve (12) year period, or during any subsequent period ending on the date when all the                                      
 requirements of Article 31.1 have been met in respect of any shares, any additional shares that have been issued in respect of those held    
 at the beginning of, or previously so issued during, any such subsequent period and all the requirements of Article 31.1 have been satisfied 
 with regard to such additional shares, the Company may also sell the additional shares.                                                      |

| 31.3 | To give effect to a sale pursuant to Article 31.1 or Article 31.2, the Board may: |

| (A) | in the case of certificated shares, authorise a person to execute an instrument of transfer of shares                                        
 in the name and on behalf of the holder of, or the person entitled by transmission to, them to the purchaser or as the purchaser may direct; 
 and                                                                                                                                          |

| (B) | in the case of uncertificated shares, exercise any power conferred on it by Article 15.10 (uncertificated 
 shares) to effect a transfer of the shares.                                                               |

| 31.4 | The purchaser will not be bound to see to the application